$19.76
2.65% yesterday
NYSE, Sep 27, 10:00 pm CET
ISIN
US29415F1049
Symbol
NVST

Envista Holdings Corp Stock price

$19.76
+1.07 5.73% 1M
-1.79 8.31% 6M
-4.30 17.87% YTD
-8.23 29.40% 1Y
-22.73 53.49% 3Y
-6.83 25.69% 5Y
-8.19 29.30% 10Y
NYSE, Closing price Fri, Sep 27 2024
+0.51 2.65%
ISIN
US29415F1049
Symbol
NVST
Sector

Key metrics

Market capitalization $3.31b
Enterprise Value $3.92b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 13.67
EV/Sales (TTM) EV/Sales 1.55
P/S ratio (TTM) P/S ratio 1.31
P/B ratio (TTM) P/B ratio 1.11
Revenue growth (TTM) Revenue growth -1.86%
Revenue (TTM) Revenue $2.53b
EBIT (operating result TTM) EBIT $217.30m
Free Cash Flow (TTM) Free Cash Flow $286.50m
Cash position $1.04b
EPS (TTM) EPS $-7.70
P/E forward negative
P/S forward 1.32
EV/Sales forward 1.57
Short interest 11.52%
Show more

Is Envista Holdings Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Envista Holdings Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Envista Holdings Corp forecast:

3x Buy
25%
8x Hold
67%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Envista Holdings Corp forecast:

Buy
25%
Hold
67%
Sell
8%

Financial data from Envista Holdings Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,534 2,534
2% 2%
100%
- Direct Costs 1,143 1,143
4% 4%
45%
1,391 1,391
6% 6%
55%
- Selling and Administrative Expenses 931 931
7% 7%
37%
- Research and Development Expense 89 89
12% 12%
4%
370 370
28% 28%
15%
- Depreciation and Amortization 153 153
5% 5%
6%
EBIT (Operating Income) EBIT 217 217
38% 38%
9%
Net Profit -1,324 -1,324
705% 705%
-52%

In millions USD.

Don't miss a Thing! We will send you all news about Envista Holdings Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Envista Holdings Corp Stock News

Neutral
PRNewsWire
about one month ago
BREA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on Wednesday, September 11, 2024 from 10:50 – 11:20 am ET at the InterContinental New York Barclay.
Positive
Seeking Alpha
about one month ago
Envista Holdings Corporation published Q2 2024 earnings results, highlighting a $1.2 billion non-cash charge from impairments. I find their valuation metrics quite attractive, comparing favorably to both the healthcare sector and their 5-year historical averages. Despite recent challenges, the company continues to generate positive free cash flows.
Neutral
Seeking Alpha
about 2 months ago
Envista Holdings Corporation (NYSE:NVST ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Stephen Keller - Principal Financial Officer Paul Keel - CEO Eric Hammes - Incoming CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley & Co. Jon Block - Stifel, Nicolaus & Company Jeff Johnson - Robert W. Baird & Co. Brandon Vazqu...
More Envista Holdings Corp News

Company Profile

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments; Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018 and is headquartered in Brea, CA.

Head office United States
CEO Paul Keel
Employees 12,800
Founded 1891
Website www.envistaco.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today